Silicone breast implants and magnetic resonance imaging screening for rupture: Do U.S. Food and Drug Administration recommendations reflect an evidence-based practice approach to patient care?

Plastic and Reconstructive Surgery

Volumn 121, Issue 4, 2008, Pages 1127-1134

  McCarthy, Colleen M ^a   Pusic, Andrea L ^b   Kerrigan, Carolyn L ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SILICONE; SILICONE DERIVATIVE;

BREAST ENDOPROSTHESIS; CLINICAL EFFECTIVENESS; EVIDENCE BASED PRACTICE; FOOD AND DRUG ADMINISTRATION; HEALTH CARE COST; HUMAN; MEDICAL DECISION MAKING; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PATIENT SATISFACTION; PREVALENCE; PRIORITY JOURNAL; PROSTHESIS FAILURE; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; RUPTURE; SCREENING; UNCERTAINTY; UNITED STATES; EVIDENCE BASED MEDICINE; FEMALE; POSTOPERATIVE COMPLICATION;

BREAST IMPLANTS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; POSTOPERATIVE COMPLICATIONS; PROSTHESIS FAILURE; SILICONES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 42949094172     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000302498.44244.52     Document Type: Review

References (54)

1. Saul, S. FDA will allow implants made of silicone. The New York Times November 18, 2006. Front page.
2. U.S. Food and Drug Administration. FDA approves silicone gel-filled breast implants after in-depth evaluation. Available at: http://www.fda.gov/bbs/ topics/NEWS/2006/NEW01512.html 2006. Accessed March 12, 2007.
3. Kassirer, J. P., and Pauker, S. G. The toss-up. N. Engl. J. Med. 305: 1467, 1981.
4. Parker, P. A., Middleton, M. S., and Kulik, J. A. Counter-factual thinking and quality of life among women with silicone breast implants. J. Behav. Med. 25: 317, 2002.
5. Obuchowski, N. A., Graham, R. J., Baker, M. E., et al. Ten criteria for effective screening: Their application to multislice CT screening for pulmonary and colorectal cancers. A.J.R. Am. J. Roentgenol. 176: 1357, 2001.
6. Lipworth, L., Tarone, R. E., and McLaughlin, J. K. Silicone breast implants and connective tissue disease: An updated review of the epidemiologic evidence. Ann. Plast. Surg. 52: 598, 2004.
7. Lipworth, L., Tarone, R. E., and McLaughlin, J. K. Breast implants and fibromyalgia: A review of the epidemiologic evidence. Ann. Plast. Surg. 52: 284, 2004.
8. Rohrich, R. J. Safety of silicone breast implants: Scientific validation/vindication at last. Plast. Reconstr. Surg. 104: 1786, 1999.
9. Hulka, B. S., Kerkvliet, N. L., and Tugwell, P. Experience of a scientific panel formed to advise the federal judiciary on silicone breast implants. N. Engl. J. Med. 342: 812, 2000.
10. Tugwell, P., Wells, G., Peterson, J., et al. Do silicone breast implants cause rheumatologic disorders? A systematic review for a court-appointed national science panel. Arthritis Rheum. 44: 2477, 2001.
11. Teuber, S. S., Reilly, D. A., Howell, L., et al. Severe migratory granulomatous reactions to silicone gel in 3 patients. J. Rheumatol. 26: 699, 1999.
12. Gebauer, B., Hohn, S., and Liebeskind, U. Silicone granuloma in intrathoracic lymph nodes after rupture of a silicone double-chamber prosthesis (in German). Rofo 176: 1331, 2004.
13. Brown, S. L., Pennello, G., Berg, W. A., et al. Silicone gel breast implant rupture, extracapsular silicone, and health status in a population of women. J. Rheumatol. 28: 996, 2001.
14. Holmich, L. R., Kjoller, K., Fryzek, J. P., et al. Self-reported diseases and symptoms by rupture status among unselected Danish women with cosmetic silicone breast implants. Plast. Reconstr. Surg. 111: 723, 2003.
15. Noone, R. B. A review of the possible health implications of silicone breast implants. Cancer 79: 1747, 1997.
16. Lahiri, A., and Waters, R. Locoregional silicone spread after high cohesive gel silicone implant rupture. J. Plast. Reconstr. Aesthet. Surg. 59: 885, 2006.
17. Holmich, L. R., Vejborg, I. M., Conrad, C., et al. Untreated silicone breast implant rupture. Plast. Reconstr. Surg. 114: 204, 2004.
18. Scaranelo, A. M., Marques, A. F., Smialowski, E. B., and Lederman, H. M. Evaluation of the rupture of silicone breast implants by mammography, ultrasonography and magnetic resonance imaging in asymptomatic patients: Correlation with surgical findings. Sao Paulo Med. J. 122: 41, 2004.
19. O'Toole, M., and Caskey, C. I. Imaging spectrum of breast implant complications: Mammography, ultrasound, and magnetic resonance imaging. Semin. Ultrasound CT MR 21: 351, 2000.
20. Beekman, W. H., Scot, M. G., Taets van Amerongen, A. H., Hage, J. J., and Mulder, J. W. Silicone breast implant bleed and rupture: Clinical diagnosis and predictive value of mammography and ultrasound. Ann. Plast. Surg. 36: 345, 1996.
21. Beekman, W. H., Hage, J. J., Taets van Amerongen, A. H., and Mulder, J. W. Accuracy of ultrasonography and magnetic resonance imaging in detecting failure of breast implants filled with silicone gel. Scand. J. Plast. Reconstr. Surg. Hand Surg. 33: 415, 1999.
22. Goodman, C. M., Cohen, V., Thornby, J., and Netscher, D. The life span of silicone gel breast implants and a comparison of mammography, ultrasonography, and magnetic resonance imaging in detecting implant rupture: A meta-analysis. Ann. Plast. Surg. 41: 577, 1998.
23. Kulmala, I., Boice, J. D., Jr., McLaughlin, J. K., et al. A feasibility study of magnetic resonance imaging of silicone breast implants in Finland. J. Long Term Eff. Med. Implants 15: 9, 2005.
24. Ikeda, D. M., Borofsky, H. B., Herfkens, R. J., Sawyer-Glover, A. M., Birdwell, R. L., and Glover, G. H. Silicone breast implant rupture: Pitfalls of magnetic resonance imaging and relative efficacies of magnetic resonance, mammography, and ultrasound. Plast. Reconstr. Surg. 104: 2054, 1999.
25. Caskey, C. I., Berg, W. A., Hamper, U. M., Sheth, S., Chang, B. W., and Anderson, N. D. Imaging spectrum of extracapsular silicone: Correlation of US, MR imaging, mammographic, and histopathologic findings. Radiographics 19: S39, 1999.
26. Cher, D. J., Conwell, J. A., and Mandel, J. S. MRI for detecting silicone breast implant rupture: Meta-analysis and implications. Ann. Plast. Surg. 47: 367, 2001.
27. Lalonde, L., David, J., and Trop, I. Magnetic resonance imaging of the breast: Current indications. Can. Assoc. Radiol. J. 56: 301, 2005.
28. Cook, R. R., Bowlin, S. J., Curtis, J. M., et al. Silicone gel breast implant rupture rates: Research issues. Ann. Plast. Surg. 48: 92, 2002.
29. Collis, N., and Sharpe, D. T. Rupture of silicone-gel breast implants. Lancet 351: 520, 1998.
30. Rohrich, R. J., Adams, W. P., Jr., Beran, S. J., et al. An analysis of silicone gel-filled breast implants: Diagnosis and failure rates. Plast. Reconstr. Surg. 102: 2304, 1998.
31. Brown, S. L., Middleton, M. S., Berg, W. A., et al. Prevalence of rupture of silicone gel breast implants revealed on MR imaging in a population of women in Birmingham, Alabama. A.J.R. Am. J. Roentgenol. 175: 1057, 2000.
32. Brown, S. L., and Pennello, G. Replacement surgery and silicone gel breast implant rupture: Self-report by women after mammoplasty. J. Womens Health Gender Based Med. 11: 255, 2002.
33. Feng, L. J., and Amini, S. B. Analysis of risk factors associated with rupture of silicone gel breast implants. Plast. Reconstr. Surg. 104: 955, 1999.
34. Holmich, L. R., Kjoller, K., Vejborg, I., et al. Prevalence of silicone breast implant rupture among Danish women. Plast. Reconstr. Surg. 108: 848, 2001.
35. Holmich, L. R., Friis, S., Fryzek, J. P., et al. Incidence of silicone breast implant rupture. Arch. Surg. 138: 801, 2003.
36. Heden, P., Bone, B., Murphy, D. K., et al. Style 410 cohesive silicone breast implants: Safety and effectiveness at 5 to 9 years after implantation. Plast. Reconstr. Surg. 118: 1281, 2006.
37. Mentor Corp. Important information for augmentation patients about Mentor MemoryGel silicone gel filled breast implants. 2007.
38. Allergan, Inc. Inamed silicone-filled breast implants (Web page). Available at: http://www.fda.gov/cdrh/pdf2/P020056c.pdf.
39. Chan, E. C. Y. Promoting an ethical approach to unproven screening imaging tests. J. Am. Coll. Radiol. 2: 311, 2005.
40. Rimer, B. K., Briss, P. A., Zeller, P. K., Chan, E. C., and Woolf, S. H. Informed decision making: What is its role in cancer screening? Cancer 101: 1214, 2004.
41. Humphrey, L. L., Helfand, M., Chan, B. K., and Woolf, S. H. Breast cancer screening: A summary of the evidence for the U.S. Preventive Services Task Force. Ann. Intern. Med. 137: 347, 2002.
42. Humphrey, L. L., Teutsch, S., and Johnson, M. Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: An update for the U.S. Preventive Services Task Force. Ann. Intern. Med. 140: 740, 2004.
43. Brindle, L. A., Oliver, S. E., Dedman, D., et al. Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK. B.J.U. Int. 98: 777, 2006.
44. Barry, M. J. The PSA conundrum. Arch. Intern. Med. 166: 7, 2006.
45. Frosch, D. L., Kaplan, R. M., and Felitti, V. The evaluation of two methods to facilitate shared decision making for men considering the prostate-specific antigen test. J. Gen. Intern. Med. 16: 391, 2001.
46. Beaulac, J. A., Fry, R. N., and Onysko, J. Lifetime and recent prostate specific antigen (PSA) screening of men for prostate cancer in Canada. Can. J. Public Health 97: 171, 2006.
47. Coulter, A. Partnerships with patients: The pros and cons of shared clinical decision-making. J. Health Serv. Res. Policy 2: 112, 1997.
48. Chiodo, G. T., and Tolle, S. W. The role of values in patients' decision making. Gen. Dent. 42: 120, 1994.
49. Sheridan, S. L., Harris, R. P., and Woolf, S. H. Shared decision making about screening and chemoprevention: A suggested approach from the U.S. Preventive Services Task Force. Am. J. Prevent. Med. 26: 56, 2004.
50. Sheridan, S. L., Felix, K., Pignone, M. P., and Lewis, C. L. Information needs of men regarding prostate cancer screening and the effect of a brief decision aid. Patient Educ. Counsel. 54: 345, 2004.
51. Briss, P., Rimer, B., Reilley, B., et al. Promoting informed decisions about cancer screening in communities and healthcare systems. Am. J. Prevent. Med. 26: 67, 2004.
52. Welch, H. G. Right and wrong reasons to be screened. Ann. Intern. Med. 140: 754, 2004.
53. Sackett, D. L., Macdonald, L., Haynes, R. B., and Taylor, D. W. Labeling of hypertensive patients. N. Engl. J. Med. 309: 1253, 1983.
54. Pickering, T. G. Now we are sick: Labeling and hypertension. J. Clin. Hypertens. (Greenwich) 8: 57, 2006.